Abcodia: Abcodia and its ovarian cancer test acquired by Oxford company
Oxford-based GENinCode plc, which is quoted on AIM, has acquired Cambridge’s ovarian cancer company Abcodia for a maximum £1 million.
Read full article »
CEO
Abcodia is a specialist firm engaged in the discovery and verification of biomarkers for the early detection and screening of cancer.
Read more